Impact of mutations conferring reduced susceptibility to lamivudine on the response to antiretroviral therapy.
Perno
C F
CF
Cozzi-Lepri
A
A
Balotta
C
C
Forbici
F
F
Violin
M
M
Bertoli
A
A
Facchi
G
G
Pezzotti
P
P
Angarano
G
G
Arici
C
C
Narciso
P
P
Orani
A
A
Raise
E
E
Scalzini
A
A
Poggio
A
A
Ippolito
G
G
Moroni
M
M
Monforte
A D
AD
D000163:Acquired Immunodeficiency Syndrome / Q000188:drug therapy*; D000328:Adult; D000368:Aged; D023241:Antiretroviral Therapy, Highly Active; D024882:Drug Resistance, Viral; D005260:Female; D054303:HIV Reverse Transcriptase / Q000235:genetics*; D006801:Humans; D019259:Lamivudine / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D009154:Mutation; D018894:Reverse Transcriptase Inhibitors / Q000627:therapeutic use*
D018894:Reverse Transcriptase Inhibitors; D019259:Lamivudine; D054303:HIV Reverse Transcriptase